FDA Investigator Emmanuel Jramos Maldonado
Emmanuel Jramos Maldonado has inspections in 1 countries as of 18 Feb 2022. Emmanuel Jramos Maldonado has collaborated with a combined 323 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
3
Last Inspection Date:
18 Feb 2022
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America
Co-Investigator(s):
Barbara J Maulfair,
Barbara J Wilimczyk,
Barbara Jwilimczyk Macri,
Cory Greene,
Douglas C Kovacs,
Emmanuel J Ramos,
Helen Verdel,
Jose M Cayuela,
Junho Pak,
Karen E D'orazio,
Matthew A Spataro,
Nancy F Scheraga,
Paul L Bellamy,
Robin P Mathew,
Rose Ljean Mary,
Stephen J Mottola,
Tara G Bizjak,
Tonia F Bernard,
Yvins Dezan
Emmanuel Jramos Maldonado's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2017 | FDA 483 | Ingenus Pharmaceuticals NJ, LLC - Form 483, 2017-09-27 |
January, 2019 | FDA 483 | Regi U.S. Inc. - Form 483, 2019-01-15 |
November, 2019 | FDA 483 | Far Hills Pharmacy - Form 483, 2019-11-14 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more